NSE: DMCC · BSE: 506405 · ISIN INE505A01010
DMCC SPECIALITY CHEMICALS LIMITED stock analysis
DMCC SPECIALITY CHEMICALS LIMITED ranks #1909 in the TickerSutra evidence-ranked universe with a score of 50/100 and 95% data confidence. The latest captured fundamentals show ROCE of 14.8%, quarterly sales growth of 99.2% and quarterly profit growth of 163.3%.Monitor only
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- CFO/EBITDA is below 0.6×
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹326cr | ₹41cr | ₹21cr | 12.0% |
| 2023 | ₹387cr | ₹36cr | ₹7cr | 9.0% |
| 2024 | ₹328cr | ₹36cr | ₹12cr | 11.0% |
| 2025 | ₹431cr | ₹57cr | ₹22cr | 13.0% |
| 2026 | ₹582cr | ₹63cr | ₹27cr | 11.0% |
| TTM | ₹707cr | ₹81cr | ₹40cr | 12.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
DMCC SPECIALITY CHEMICALS LIMITED has informed the Exchange regarding Corrigendum to the 105th Annual Report for the Financial Year 2025-2026.
RoutineDMCC Speciality Chemicals Ltd - 506405 - Corrigendum To The 105Th Annual Report For The Financial Year 2025-2026BSE · 10 Sept 2026Corrigendum to the 105th Annual Report for the financial year 2025-26.
MANAGEMENT COMMENTARY
Signals from filed documents
Indian manufacturers benefited from rising export opportunities, deeper integration into global value chains and improved customer diversification, supported Statutory Reports Financial StatementsStrategic Review 36 37DMCC Speciality Chemicals Limited Annual Report 2025-26 by investment in R&D, process innovation and capacity expansion. Challenges persisted in the form of pricing pressure from global oversupply, risi
The speciality chemicals segment continued to outperform, driven by rising global demand for high-performance and value-added products and by the ongoing supply chain realignment under the China-plus-one strategy. Indian manufacturers benefited from rising export opportunities, deeper integration into global value chains and improved customer diversification, supported Statutory Reports Financial StatementsStrategic
Our diversified customer base includes leading domestic and global companies across pharmaceuticals, specialty chemicals, industrial chemicals, agrochemicals, coatings and performance materials sectors. Despite persistent volatility in raw material prices and a challenging global business environment, the Company maintained business momentum through disciplined operations, diversified product offerings and strong cus
Simultaneously, its integrated manufacturing infrastructure, strong customer relationships and sustainability-led operational model continue to reinforce margin resilience and business stability. By leveraging deep expertise in sulphur and boron chemistry, the R&D team continues to support product diversification, operational optimisation and expansion into niche industrial applications with higher margin potential.
We will continue to earn it through steady, disciplined execution. Goculdas Managing Director and Chief Executive Officer Statutory Reports Financial StatementsDMCC Speciality Chemicals Limited Annual Report 2025-26 Strategic Review 1 3 2 4 Driving Sustainable Competitive Advantage DMCC’s growth strategy is anchored in strengthening its differentiated position across sulphur and boron chemistries through specialty pr
India’s structural advantages, including cost competitiveness, a diversified manufacturing base and favourable policy support, enabled the industry to sustain momentum even as global demand remained uneven. The sector faced margin pressure from volatility in feedstock and energy prices, while excess supply from global markets, particularly China, weighed on pricing in select segments. Export competitiveness was also
This growth is underpinned by continued expansion in industrial manufacturing, infrastructure development, agrochemical demand, personal care consumption and oil and gas processing. The market is expected to grow to US$7.58 trillion by 2030, registering a CAGR of 7.5%, driven by increasing demand for speciality chemicals, rising investment in advanced manufacturing technologies, stronger regulatory focus on sustainab
Bulk Chemicals The bulk chemicals segment was the principal driver of revenue growth in FY2026, supported almost entirely by domestic demand. Sulphur, the key raw material for the segment, recorded a steady and substantial price increase through the year. Tight global availability was compounded in the second half by disruption to shipments through the Strait of Hormuz, the route for a significant share of world sulp
d) We have proposed the installation of an oleum preheater to conserve valuable steam for SO3 generation. This capital expenditure (CAPEX) has been approved by the board, and we anticipate steam savings of 36 MT per day. The execution of this project will occur during scheduled opportunities or the annual shutdown only.
The Vigil Mechanism/Whistle Blower Policy is available on the website of the Company under weblink https://www.dmcc.com/Media/pdf/Whistle- Blower-Vigil-Mechanism_DMCC.pdf Your Company affirms that no Director/Employee of the Company has been denied access to the Chairman of the Audit Committee and no complaint has been received during the year under review. h) Details of utilization of funds raised through preferenti
Much of the revenue growth reflected higher realisations in sulphuric acid, which in turn followed a sharp escalation in sulphur prices through the year. We passed the increase in raw material costs through to our customers and protected profitability on an absolute basis. In percentage terms, the EBITDA margin moderated to 11.04% from 13.49% in the previous year.
And the proceeds of that land, once monetized, would be used for what? Bimal Goculdas: Well, we could use it for CAPEX or debt reduction. Bimal Goculdas: Very much out of my control.
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…